MedTrace Logo

Genetic Causes of Gestational Diabetes in the Emirati Population

NCT03589092 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2020-06-25

No results posted yet for this study

Summary

The study aims to identify the number of MODY patients to be found among Emirati women with GDM as the incidence and prevalence of monogenic diabetes among this group of patients is unknown. This will enable improvements in diagnostics, treatment and the counselling of these women.

Conditions

  • Gestational Diabetes
  • GDM
  • Maturity-onset Diabetes of the Young
  • MODY

Interventions

GENETIC

Next generation sequencing (NGS)

NGS Panel, Whole exome/genome sequencing

Sponsors & Collaborators

  • Imperial College London Diabetes Centre

    lead OTHER

Principal Investigators

  • Maha Barakat, PhD FRCP · Imperial College London Diabetes Centre

  • Torben Hansen, MD PhD · University of Copenhagen

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03589092 on ClinicalTrials.gov